XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Preferred Stock
Common Stock
Capital in Excess of Par
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022     12,171,512       1,471,406
Beginning balance at Dec. 31, 2022 $ 36,169,432 $ 0 $ 121,715 $ 74,519,590 $ (15,958,428) $ (16,945,964) $ (5,567,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 636,178     636,178      
Net income (loss) (9,114,298)         (9,114,298)  
Change in unrealized losses on available-for-sale securities, net of tax (1,161,051)       (1,161,051)    
Vesting of restricted stock awards (in shares)     56,977        
Vesting of restricted stock awards 0   $ 569 (569)      
Shares deducted from restricted stock awards for payment of withholding taxes (in shares)     (927)        
Shares deducted from restricted stock awards for payment of withholding taxes $ (1,400)   $ (9) (1,391)      
Exercise of stock options (in shares) 0            
Ending balance (in shares) at Sep. 30, 2023     12,227,562       1,471,406
Ending balance at Sep. 30, 2023 $ 26,528,861 0 $ 122,275 75,153,808 (17,119,479) (26,060,262) $ (5,567,481)
Beginning balance (in shares) at Jun. 30, 2023     12,227,562       1,471,406
Beginning balance at Jun. 30, 2023 32,085,216 0 $ 122,275 74,946,685 (14,893,572) (22,522,691) $ (5,567,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 207,123     207,123      
Net income (loss) (3,537,571)         (3,537,571)  
Change in unrealized losses on available-for-sale securities, net of tax $ (2,225,907)       (2,225,907)    
Exercise of stock options (in shares) 0            
Ending balance (in shares) at Sep. 30, 2023     12,227,562       1,471,406
Ending balance at Sep. 30, 2023 $ 26,528,861 0 $ 122,275 75,153,808 (17,119,479) (26,060,262) $ (5,567,481)
Beginning balance (in shares) at Dec. 31, 2023     12,248,313       1,471,406
Beginning balance at Dec. 31, 2023 34,504,139 0 $ 122,483 75,338,010 (12,274,563) (23,114,310) $ (5,567,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 906,375     906,375      
Net income (loss) 12,919,761         12,919,761  
Vesting of restricted stock awards (in shares)     446,044        
Vesting of restricted stock awards 0   $ 4,460 (4,460)      
Shares deducted from restricted stock awards for payment of withholding taxes (in shares)     (109,633)        
Shares deducted from restricted stock awards for payment of withholding taxes $ (961,091)   $ (1,096) (959,995)      
Exercise of stock options (in shares) 12,731   37,959       35,248
Exercise of stock options $ 0   $ 380 (28)     $ (352)
Exercise of warrants (in shares)     60,557        
Exercise of warrants 0   $ 606 (606)      
Issuance of common stock, net of offering (in shares)     1,135,710        
Issuance of common stock, net of offering costs 9,066,098   $ 11,357 9,054,741      
Change in unrealized gains on available-for-sale securities, net of tax 3,234,450       3,234,450    
Ending balance (in shares) at Sep. 30, 2024     13,818,950       1,506,654
Ending balance at Sep. 30, 2024 59,669,732 0 $ 138,190 84,334,037 (9,040,113) (10,194,549) $ (5,567,833)
Beginning balance (in shares) at Jun. 30, 2024     12,536,129       1,471,406
Beginning balance at Jun. 30, 2024 40,802,774 0 $ 125,361 76,042,147 (12,624,559) (17,172,694) $ (5,567,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 359,170     359,170      
Net income (loss) 6,978,145         6,978,145  
Vesting of restricted stock awards (in shares)     211,391        
Vesting of restricted stock awards 0   $ 2,114 (2,114)      
Shares deducted from restricted stock awards for payment of withholding taxes (in shares)     (106,687)        
Shares deducted from restricted stock awards for payment of withholding taxes $ (952,711)   $ (1,067) (951,644)      
Exercise of stock options (in shares) 12,731   37,959       35,248
Exercise of stock options $ 0   $ 380 (28)     $ (352)
Exercise of warrants (in shares)     60,557        
Exercise of warrants 0   $ 606 (606)      
Issuance of common stock, net of offering (in shares)     1,079,601        
Issuance of common stock, net of offering costs 8,897,908   $ 10,796 8,887,112      
Change in unrealized gains on available-for-sale securities, net of tax 3,584,446       3,584,446    
Ending balance (in shares) at Sep. 30, 2024     13,818,950       1,506,654
Ending balance at Sep. 30, 2024 $ 59,669,732 $ 0 $ 138,190 $ 84,334,037 $ (9,040,113) $ (10,194,549) $ (5,567,833)